Cargando…

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway

Poly(ADP-ribosyl)ation is known to be involved in a variety of cellular processes, such as DNA repair, cell death, telomere regulation, genomic stability and cell differentiation by poly(ADP-ribose) polymerase (PARP). While PARP inhibitors are presently under clinical investigation for cancer therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishi, Yuta, Fujihara, Hisako, Kawaguchi, Koji, Yamada, Hiroyuki, Nakayama, Ryoko, Yamamoto, Nanami, Fujihara, Yuko, Hamada, Yoshiki, Satomura, Kazuhito, Masutani, Mitsuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632778/ https://www.ncbi.nlm.nih.gov/pubmed/26492236 http://dx.doi.org/10.3390/ijms161024820

Ejemplares similares

Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
por: Yasukawa, Masaaki, et al.
Publicado: (2016)

Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo
por: Nakamura, Nanami, et al.
Publicado: (2022)

Spontaneous Development of Dental Dysplasia in Aged Parp-1 Knockout Mice
por: Fujihara, Hisako, et al.
Publicado: (2019)

Detection accuracy for epithelial dysplasia using an objective autofluorescence visualization method based on the luminance ratio
por: Yamamoto, Nanami, et al.
Publicado: (2017)

Temporal progression of PARP activity in the Prph2 mutant rd2 mouse: Neuroprotective effects of the PARP inhibitor PJ34
por: Sahaboglu, Ayse, et al.
Publicado: (2017)

Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells
por: Bai, Xue Tao, et al.
Publicado: (2015)

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013)

PJ accu (?)
Publicado: (1989)

Influence of PJ34 on the genotoxicity induced by melphalan in human multiple myeloma cells
por: Xiong, Ting, et al.
Publicado: (2015)

PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD(+) levels and increasing SIRT1 activity
por: Zha, Siyuan, et al.
Publicado: (2018)

PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells
por: Cseh, Anna Maria, et al.
Publicado: (2019)

Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD(+) levels and increasing SIRT1 activity
por: Zha, Siyuan, et al.
Publicado: (2018)

Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34
por: Shen, Yan, et al.
Publicado: (2016)

The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
por: Visochek, Leonid, et al.
Publicado: (2019)

The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells
por: Cohen-Armon, Malka
Publicado: (2020)

Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
por: Visochek, Leonid, et al.
Publicado: (2020)

ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells
por: Roper, Stephen J., et al.
Publicado: (2014)

Impairment in S-phase entry of splenocytes of Parp-1 knockout mice
por: Watanabe, Fumiaki, et al.
Publicado: (2004)

Solitary myofibroma of the mandible in an adult with magnetic resonance imaging and positron emission tomography findings: a case report
por: Tanaka, Yoko, et al.
Publicado: (2014)

The Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitor PJ34 Reduces Pulmonary Ischemia-Reperfusion Injury in Rats
por: Hatachi, Go, et al.
Publicado: (2014)

763 The Cardioprotective Effects of Sildenafil, PJ34, MitoTEMPO, and ZLN005 in the Early After Burn Injury
por: Radhakrishnan, Ravi, et al.
Publicado: (2023)

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles
por: Araki, Tomonori, et al.
Publicado: (2022)

Upregulation of Salmonella-Induced IL-6 Production in Caco-2 Cells by PJ-34, PARP-1 Inhibitor: Involvement of PI3K, p38 MAPK, ERK, JNK, and NF-κB
por: Huang, Fu-Chen
Publicado: (2009)

Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain
por: Bonnin, Philippe, et al.
Publicado: (2021)

Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors
por: Wang, Junhui, et al.
Publicado: (2015)

Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway
por: Bonnin, Philippe, et al.
Publicado: (2020)

Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities
por: Berasi, Stephen P, et al.
Publicado: (2011)

PARP Inhibitor Decreases Akt Phosphorylation and Induces Centrosome Amplification and Chromosomal Aneuploidy in CHO-K1 Cells
por: Tanaka, Masakazu, et al.
Publicado: (2022)

XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA
por: Hirota, Kouji, et al.
Publicado: (2022)

Current practice patterns of osteoporosis treatment in cancer patients and effects of therapeutic interventions in a tertiary center
por: Fujihara, Nasa, et al.
Publicado: (2021)

Author Correction: Requirement of direct contact between chondrocytes and macrophages for the maturation of regenerative cartilage
por: Kanda, Kengo, et al.
Publicado: (2022)

Requirement of direct contact between chondrocytes and macrophages for the maturation of regenerative cartilage
por: Kanda, Kengo, et al.
Publicado: (2021)

The Development of Sustainable Engineering with PjBL during the COVID-19 Pandemic †
por: Hayashi, Victor Takashi, et al.
Publicado: (2023)

Erratum to “Impairment in S-phase entry of splenocytes of Parp-1 knockout mice”: [Proc. Jpn. Acad., Ser. B 79, No. 8, 248–251 (2003)]
por: Watanabe, Fumiaki, et al.
Publicado: (2004)

The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal Suppression
por: Kinnett, Kathi, et al.
Publicado: (2017)

Developing an in vivo porcine model of duct‐to‐mucosa pancreaticojejunostomy (Yonsei‐PJ(DTM))
por: Choi, Munseok, et al.
Publicado: (2020)

Zbp1-positive cells are osteogenic progenitors in periodontal ligament
por: Ueda, Tsugumi, et al.
Publicado: (2021)

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells
por: Ogino, Hideki, et al.
Publicado: (2007)

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells
por: Ogino, Hideki, et al.
Publicado: (2007)

Another “String to the Bow” of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y(12) Antagonism?
por: Lechaftois, Marie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_149gfadjf6pavt77pq16ngtefe